These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 15937309

  • 1. Combined use of 99mTc-sestamibi and 99mTc-V-DMSA in the assessment of chemotherapy effectiveness in patients with multiple myeloma.
    Koutsikos J, Athanasoulis T, Anagnostopoulos A, Velidaki A, Passadi M, Dimopoulos MA, Zerva C.
    J Nucl Med; 2005 Jun; 46(6):978-82. PubMed ID: 15937309
    [Abstract] [Full Text] [Related]

  • 2. Reverse of the differential uptake intensity of Tc-99m MIBI and Tc-99m V-DMSA by multiple myeloma lesions in response to therapy.
    Athanasoulis T, Koutsikos J, Moulopoulos LA, Tsiouris S, Dimopoulos MA, Zerva C.
    Clin Nucl Med; 2003 Aug; 28(8):631-5. PubMed ID: 12897645
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic value of 99mTc-methylene diphosphonate and 99mTc-pentavalent DMSA compared with 99mTc-sestamibi for palpable breast lesions.
    Massardo T, Alonso O, Kabasakal L, Llamas-Olier A, Shankar UR, Zhu H, Delgado L, González P, Mut F, Padhy AK.
    J Nucl Med; 2002 Jul; 43(7):882-8. PubMed ID: 12097457
    [Abstract] [Full Text] [Related]

  • 4. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.
    Balleari E, Villa G, Garrè S, Ghirlanda P, Agnese G, Carletto M, Clavio M, Ferrando F, Gobbi M, Mariani G, Ghio R.
    Haematologica; 2001 Jan; 86(1):78-84. PubMed ID: 11146575
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tc 99m Sestamibi Scanning in Multiple Myeloma--a New look with SPECT-CT.
    Luthra K, Bhave A, Lele RD.
    J Assoc Physicians India; 2014 Sep; 62(9):801-12. PubMed ID: 26259316
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pentavalent technetium-99m-DMSA uptake in a patient having multiple myeloma without amyloidosis.
    Ohnishi T, Noguchi S, Murakami N, Tajiri J, Morita M, Tamaru M, Hoshi H, Watanabe K.
    J Nucl Med; 1991 Sep; 32(9):1785-7. PubMed ID: 1652629
    [Abstract] [Full Text] [Related]

  • 11. (99m)Technetium pentavalent dimercaptosuccinic acid scintigraphy in the follow-up of clinically nonfunctioning pituitary adenomas after radiotherapy.
    Colao A, Ferone D, Lombardi G, Lastoria S.
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):713-21. PubMed ID: 12072040
    [Abstract] [Full Text] [Related]

  • 12. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
    Ambrus E, Rajtár M, Ormándi K, Séra T, Tószegi A, Láng J, Pávics L, Csernay L.
    Anticancer Res; 1997 Jun; 17(3B):1599-605. PubMed ID: 9179201
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT: does it have a place in predicting survival in patients with glioblastoma multiforme?
    Amin A, Mustafa M, Abd El-Hadi E, Monier A, Badwey A, Saad E.
    J Neurooncol; 2015 Jan; 121(2):303-9. PubMed ID: 25349131
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic efficacy of technetium-99m pentavalent-dimercapto succinic acid versus gallium-67 citrate, imaging in patients with highly suspected acute bone and joint infections.
    Koukouraki S, Gaitanis I, Hatjipaulou A, Karkavitsas N.
    Hell J Nucl Med; 2006 Jan; 9(2):99-102. PubMed ID: 16894413
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer.
    Papantoniou VJ, Souvatzoglou MA, Valotassiou VJ, Louvrou AN, Ambela C, Koutsikos J, Lazaris D, Christodoulidou JK, Sotiropoulou MG, Melissinou MJ, Perperoglou A, Tsiouris S, Zerva CJ.
    Breast Cancer Res; 2004 Jan; 6(2):R56-62. PubMed ID: 14979918
    [Abstract] [Full Text] [Related]

  • 19. Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up.
    Pace L, Catalano L, Del Vecchio S, Di Gennaro F, De Renzo A, Sica G, Califano C, Tedesco N, Borrelli G, Rotoli B, Salvatore M.
    Eur J Nucl Med; 2001 Mar; 28(3):304-12. PubMed ID: 11315597
    [Abstract] [Full Text] [Related]

  • 20. Comparison of Tc-99m sestamibi and TI-201 uptake in multiple myeloma.
    Chun KA, Cho IH, Won KC, Lee KH, Lee HW, Hyun MS, Hayashida K.
    Clin Nucl Med; 2001 Mar; 26(3):212-5. PubMed ID: 11245112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.